Meta-analysis results: BMI versus esophageal adenocarcinoma
. | BMI category (versus normal weight) . | OR (95% CI) . | Phomogeneity . | No. studies . | ||||
---|---|---|---|---|---|---|---|---|
Overall | ||||||||
Both gender | Overweight + obese | 1.7 (1.6-1.9) | <0.01 | 11 | ||||
Males | Overweight + obese | 2.2 (1.7-2.7) | 0.01 | 6 | ||||
Females | Overweight + obese | 2.0 (1.4-2.9) | 0.20 | 5 | ||||
Esophageal adenocarcinoma only | ||||||||
Both genders | Overweight | 1.9 (1.5-2.4) | 0.02 | 6 | ||||
Obese | 2.4 (2.0-2.8) | <0.01 | 6 | |||||
Overweight + obese | 2.1 (1.7-2.4) | 0.01 | 7 | |||||
Males | Overweight | 1.8 (1.5-2.2) | 0.93 | 3 | ||||
Obese | 2.4 (1.9-3.2) | 0.35 | 3 | |||||
Overweight + obese | 2.2 (1.8-2.7) | 0.11 | 4 | |||||
Females | Overweight | 1.5 (1.1-2.2) | 0.57 | 3 | ||||
Obese | 2.1 (1.4-3.2) | 0.94 | 3 | |||||
Overweight + obese | 1.9 (1.5-2.5) | 0.20 | 5 |
. | BMI category (versus normal weight) . | OR (95% CI) . | Phomogeneity . | No. studies . | ||||
---|---|---|---|---|---|---|---|---|
Overall | ||||||||
Both gender | Overweight + obese | 1.7 (1.6-1.9) | <0.01 | 11 | ||||
Males | Overweight + obese | 2.2 (1.7-2.7) | 0.01 | 6 | ||||
Females | Overweight + obese | 2.0 (1.4-2.9) | 0.20 | 5 | ||||
Esophageal adenocarcinoma only | ||||||||
Both genders | Overweight | 1.9 (1.5-2.4) | 0.02 | 6 | ||||
Obese | 2.4 (2.0-2.8) | <0.01 | 6 | |||||
Overweight + obese | 2.1 (1.7-2.4) | 0.01 | 7 | |||||
Males | Overweight | 1.8 (1.5-2.2) | 0.93 | 3 | ||||
Obese | 2.4 (1.9-3.2) | 0.35 | 3 | |||||
Overweight + obese | 2.2 (1.8-2.7) | 0.11 | 4 | |||||
Females | Overweight | 1.5 (1.1-2.2) | 0.57 | 3 | ||||
Obese | 2.1 (1.4-3.2) | 0.94 | 3 | |||||
Overweight + obese | 1.9 (1.5-2.5) | 0.20 | 5 |